Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

dc.contributor.authorvan der Pluijm R.W.
dc.contributor.authorPeto T.J.
dc.contributor.authorHamaluba M.
dc.contributor.authorCallery J.J.
dc.contributor.authorTripura R.
dc.contributor.authorWhite N.J.
dc.contributor.authorDondorp A.M.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:49:50Z
dc.date.available2023-06-18T17:49:50Z
dc.date.issued2022-06-01
dc.identifier.citationThe Lancet Infectious Diseases Vol.22 No.6 (2022) , 765-766
dc.identifier.doi10.1016/S1473-3099(22)00283-3
dc.identifier.eissn14744457
dc.identifier.issn14733099
dc.identifier.pmid35643100
dc.identifier.scopus2-s2.0-85130531455
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/85827
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleIs triple artemisinin-based combination therapy necessary for uncomplicated malaria?
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85130531455&origin=inward
oaire.citation.endPage766
oaire.citation.issue6
oaire.citation.startPage765
oaire.citation.titleThe Lancet Infectious Diseases
oaire.citation.volume22
oairecerif.author.affiliationWellcome Trust Research Laboratories Nairobi
oairecerif.author.affiliationMahidol University

Files

Collections